{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:26:33Z","timestamp":1780611993715,"version":"3.54.1"},"reference-count":88,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Antithrombotic medications (ATMs), including antiplatelet therapy (APT) and oral anticoagulants (OACs), are widely used in current clinical practice for the prevention and treatment of a variety of cardiovascular diseases, deep vein thrombosis, and pulmonary thromboembolisms. The long-term usage of these drugs, associated with an inherent risk of bleeding, raises concerns for unruptured cerebrovascular malformations (UCVMs), such as arteriovenous malformations (AVMs), cerebral cavernous malformations (CCMs), and intracranial aneurysms (IAs), in which the bleeding risk also poses a major threat. The aim of this study was to assess the safety and risk-benefit ratio of ATMs in these various neurosurgical diseases and to give neurosurgeons a safe and reasonable choice regarding whether to administer ATMs to these patients during the course of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors conducted a systematic review of the literature (PubMed\/MEDLINE and Embase) according to Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines, which yielded 4 papers about CCMs, 2 about AVMs, and 9 about IAs. The risk of bias was assessed using the Cochrane Collaboration\u2019s tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>For AVMs, only 2 studies with a total of only 14 patients were included. Data on AVMs and ATMs are limited and weak, relying on small case series. Nevertheless, there is no evidence for either an increased risk of intracranial hemorrhage in patients with AVMs who are receiving ATMS or the need to interrupt ATMs in those patients who have been diagnosed with sporadic, unruptured brain AVMs. With respect to CCMs, the literature search resulted in 4 cohort studies and 1 meta-analysis. These studies affirmed the absence of a correlation between ATMs and an increased risk of CCM bleeding while simultaneously suggesting a protective role of ATMs against bleeding. Concerning IAs, the topic is more complex and debated, despite larger case series on IAs than on AVMs or CCMs. The benefits of ATMs for IAs may vary according to the type of intervention and specific drug administered. Evidence supports the continuation of long-term APT for all patients newly diagnosed with an IA, whereas starting APT in patients with incidentally discovered IA as a means of prophylaxis against rupture is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>The findings of this review should be taken as a wide overview of UCVM and ATM. Future research should consider the relationship of AVM, CCM, and IA with APT and OAC independently.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2023.7.focus23117","type":"journal-article","created":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T09:27:58Z","timestamp":1696152478000},"page":"E14","source":"Crossref","is-referenced-by-count":9,"title":["To use or not to use antithrombotics in unruptured cerebrovascular malformations? A systematic review focusing on this clinical and surgical dilemma"],"prefix":"10.3171","volume":"55","author":[{"given":"Andrea","family":"Bianconi","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Section of Neurosurgery, AOU Citt\u00e0 della Salute e della Scienza, University of Turin, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ceraudo","sequence":"additional","affiliation":[{"name":"Neurosurgery, IRCCS Policlinico San Martino, Genova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Nico","sequence":"additional","affiliation":[{"name":"Neurosurgery, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Minardi","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Section of Neurosurgery, AOU Citt\u00e0 della Salute e della Scienza, University of Turin, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Allevi","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Section of Neurosurgery, AOU Citt\u00e0 della Salute e della Scienza, University of Turin, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Prior","sequence":"additional","affiliation":[{"name":"Neurosurgery, IRCCS Policlinico San Martino, Genova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Garbossa","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Section of Neurosurgery, AOU Citt\u00e0 della Salute e della Scienza, University of Turin, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zona","sequence":"additional","affiliation":[{"name":"Neurosurgery, IRCCS Policlinico San Martino, Genova, Italy;"},{"name":"Section of Neurosurgery, Department of Neuroscienze, Riabilitazione, Section of Neurosurgery, Oftalmologia, Genetica e Scienze Materno-Infantili, University of Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Fiaschi","sequence":"additional","affiliation":[{"name":"Neurosurgery, IRCCS Policlinico San Martino, Genova, Italy;"},{"name":"Section of Neurosurgery, Department of Neuroscienze, Riabilitazione, Section of Neurosurgery, Oftalmologia, Genetica e Scienze Materno-Infantili, University of Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"1","key":"b1","series-title":"Neurosurg Rev","first-page":"485","article-title":"Clinical practice for antiplatelet and anticoagulant therapy in neurosurgery: data from an Italian survey and summary of current recommendations\u2014part I, antiplatelet therapy","volume":"44","author":"Fiaschi P","year":"2021","unstructured":"Fiaschi P, Iaccarino C, Stefini R, Prior E, Prior A, Zona G. Clinical practice for antiplatelet and anticoagulant therapy in neurosurgery: data from an Italian survey and summary of current recommendations\u2014part I, antiplatelet therapy. Neurosurg Rev. 2021;44(1):485\u2013493."},{"issue":"1","key":"b2","series-title":"BMC Neurol","first-page":"98","article-title":"How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH)","volume":"21","author":"Prior A","year":"2021","unstructured":"Prior A, Fiaschi P, Iaccarino C,  How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH). BMC Neurol. 2021;21(1):98."},{"issue":"2","key":"b3","series-title":"J Neurosurg Sci","first-page":"236","article-title":"Anticoagulant therapy in high grade gliomas: a systematic review on state of the art and future perspectives","volume":"67","author":"Bianconi A","year":"2023","unstructured":"Bianconi A, Prior A, Zona G, Fiaschi P. Anticoagulant therapy in high grade gliomas: a systematic review on state of the art and future perspectives. J Neurosurg Sci. 2023;67(2):236\u2013240."},{"issue":"24","key":"b4","series-title":"J Am Coll Cardiol","first-page":"2987","article-title":"Meta-analysis of reversal agents for severe bleeding associated with direct oral anticoagulants","volume":"77","author":"G\u00f3mez-Outes A","year":"2021","unstructured":"G\u00f3mez-Outes A, Alcubilla P, Calvo-Rojas G,  Meta-analysis of reversal agents for severe bleeding associated with direct oral anticoagulants. J Am Coll Cardiol. 2021;77(24):2987\u20133001."},{"issue":"2","key":"b5","series-title":"J Neurol","first-page":"664","article-title":"Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials","volume":"269","author":"Wu T","year":"2022","unstructured":"Wu T, Lv C, Wu L,  Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. J Neurol. 2022;269(2):664\u2013675."},{"issue":"9","key":"b6","series-title":"BMJ Open","first-page":"e046741","article-title":"Continuation versus discontinuation of aspirin-based antiplatelet therapy for perioperative bleeding and ischaemic events in adults undergoing neurosurgery: protocol for a systematic review and meta-analysis","volume":"11","author":"Wang X","year":"2021","unstructured":"Wang X, Wang X, Yu Y, Han R. Continuation versus discontinuation of aspirin-based antiplatelet therapy for perioperative bleeding and ischaemic events in adults undergoing neurosurgery: protocol for a systematic review and meta-analysis. BMJ Open. 2021;11(9):e046741."},{"issue":"1","key":"b7","series-title":"Acta Neurochir (Wien)","first-page":"39","article-title":"Risks and benefits of continuation and discontinuation of aspirin in elective craniotomies: a systematic review and pooled-analysis","volume":"165","author":"Rychen J","year":"2023","unstructured":"Rychen J, Saemann A, Fingerlin T,  Risks and benefits of continuation and discontinuation of aspirin in elective craniotomies: a systematic review and pooled-analysis. Acta Neurochir (Wien). 2023;165(1):39\u201347."},{"issue":"1","key":"b8","series-title":"Neurocrit Care","first-page":"6","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine","volume":"24","author":"Frontera JA","year":"2016","unstructured":"Frontera JA, Lewin JJ III, Rabinstein AA,  Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24(1):6\u201346."},{"issue":"7829","key":"b9","series-title":"BMJ","first-page":"d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JPT","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC,  The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(7829):d5928."},{"issue":"8","key":"b10","series-title":"Intern Emerg Med","first-page":"1227","article-title":"Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study","volume":"13","author":"Sturiale CL","year":"2018","unstructured":"Sturiale CL, Pignotti F, Giordano M,  Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study. Intern Emerg Med. 2018;13(8):1227\u20131232."},{"issue":"12","key":"b11","series-title":"Ann Hematol","first-page":"1959","article-title":"Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation","volume":"91","author":"Edwards CP","year":"2012","unstructured":"Edwards CP, Shehata N, Faughnan ME. Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation. Ann Hematol. 2012;91(12):1959\u20131968."},{"issue":"10","key":"b12","series-title":"Lancet Neurol","first-page":"935","article-title":"Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis","volume":"18","author":"Zuurbier SM","year":"2019","unstructured":"Zuurbier SM, Hickman CR, Tolias CS,  Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol. 2019;18(10):935\u2013941."},{"issue":"6","key":"b13","series-title":"J Neurosurg","first-page":"1922","article-title":"Antithrombotic medication and bleeding risk in patients with cerebral cavernous malformations: a cohort study","volume":"130","author":"Bervini D","year":"2019","unstructured":"Bervini D, Jaeggi C, Mordasini P, Schucht P, Raabe A. Antithrombotic medication and bleeding risk in patients with cerebral cavernous malformations: a cohort study. J Neurosurg. 2019;130(6):1922\u20131930."},{"issue":"12","key":"b14","series-title":"Stroke","first-page":"3196","article-title":"Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations","volume":"43","author":"Schneble HM","year":"2012","unstructured":"Schneble HM, Soumare A, Herv\u00e9 D,  Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke. 2012;43(12):3196\u20133199."},{"issue":"1","key":"b15","series-title":"J Neurosurg","first-page":"43","article-title":"Use of antithrombotic agents in patients with intracerebral cavernous malformations","volume":"118","author":"Flemming KD","year":"2013","unstructured":"Flemming KD, Link MJ, Christianson TJH, Brown RD Jr. Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg. 2013;118(1):43\u201346."},{"key":"b16","series-title":"Clin Neurol Neurosurg","first-page":"93","article-title":"Impact of antithrombotic treatment on clinical outcomes after craniotomy for unruptured intracranial aneurysm","volume":"161","author":"Nakamizo A","year":"2017","unstructured":"Nakamizo A, Michiwaki Y, Kawano Y,  Impact of antithrombotic treatment on clinical outcomes after craniotomy for unruptured intracranial aneurysm. Clin Neurol Neurosurg. 2017;161:93\u201397."},{"issue":"6","key":"b17","series-title":"World Neurosurg","first-page":"1127","article-title":"Aspirin and aneurysmal subarachnoid hemorrhage","volume":"82","author":"Gross BA","year":"2014","unstructured":"Gross BA, Rosalind Lai PM, Frerichs KU, Du R. Aspirin and aneurysmal subarachnoid hemorrhage. World Neurosurg. 2014;82(6):1127\u20131130."},{"issue":"6","key":"b18","series-title":"J Neurosurg","first-page":"1611","article-title":"Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment","volume":"119","author":"Simard JM","year":"2013","unstructured":"Simard JM, Aldrich EF, Schreibman D, James RF, Polifka A, Beaty N. Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment. J Neurosurg. 2013;119(6):1611\u20131619."},{"issue":"5","key":"b19","series-title":"Interv Neuroradiol","first-page":"532","article-title":"Outcome of flow diverter placement for intracranial aneurysm with dual antiplatelet therapy and oral anticoagulant therapy","volume":"26","author":"Fujii T","year":"2020","unstructured":"Fujii T, Oishi H, Teranishi K, Yatomi K, Suzuki K, Arai H. Outcome of flow diverter placement for intracranial aneurysm with dual antiplatelet therapy and oral anticoagulant therapy. Interv Neuroradiol. 2020;26(5):532\u2013538."},{"issue":"6","key":"b20","series-title":"J Neurosurg","first-page":"921","article-title":"Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage","volume":"101","author":"Toussaint LG III","year":"2004","unstructured":"Toussaint LG III, Friedman JA, Wijdicks EFM,  Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;101(6):921\u2013925."},{"issue":"1","key":"b21","series-title":"Neurosurgery","first-page":"77","article-title":"Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with unruptured aneurysms","volume":"84","author":"Narata AP","year":"2019","unstructured":"Narata AP, Amelot A, Bibi R,  Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with unruptured aneurysms. Neurosurgery. 2019;84(1):77\u201383."},{"key":"b22","series-title":"World Neurosurg","first-page":"e132","article-title":"Patients taking antithrombotic medications present less frequently with ruptured aneurysms","volume":"136","author":"Nisson PL","year":"2020","unstructured":"Nisson PL, Meybodi T, Secomb TW, Berger GK, Roe DJ, Lawton MT. Patients taking antithrombotic medications present less frequently with ruptured aneurysms. World Neurosurg. 2020;136:e132\u2013e140."},{"issue":"11","key":"b23","series-title":"Stroke","first-page":"3156","article-title":"Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture","volume":"42","author":"Hasan DM","year":"2011","unstructured":"Hasan DM, Mahaney KB, Brown RD Jr,  Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke. 2011;42(11):3156\u20133162."},{"issue":"2","key":"b24","series-title":"J Neurosurg","first-page":"537","article-title":"The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis","volume":"126","author":"Dasenbrock HH","year":"2017","unstructured":"Dasenbrock HH, Yan SC, Gross BA,  The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis. J Neurosurg. 2017;126(2):537\u2013547."},{"issue":"2","key":"b25","series-title":"J Neurosurg","first-page":"302","article-title":"Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis","volume":"127","author":"Brinjikji W","year":"2017","unstructured":"Brinjikji W, Iyer VN, Wood CP, Lanzino G. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis. J Neurosurg. 2017;127(2):302\u2013310."},{"issue":"2","key":"b26","series-title":"Lancet Neurol","first-page":"166","article-title":"Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data","volume":"15","author":"Horne MA","year":"2016","unstructured":"Horne MA, Flemming KD, Su IC,  Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol. 2016;15(2):166\u2013173."},{"issue":"5","key":"b27","series-title":"Stroke","first-page":"1210","article-title":"Aspirin and risk of subarachnoid hemorrhage: systematic review and meta-analysis","volume":"48","author":"Phan K","year":"2017","unstructured":"Phan K, Moore JM, Griessenauer CJ, Ogilvy CS, Thomas AJ. Aspirin and risk of subarachnoid hemorrhage: systematic review and meta-analysis. Stroke. 2017;48(5):1210\u20131217."},{"issue":"9","key":"b28","series-title":"Stroke","first-page":"2285","article-title":"Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review","volume":"34","author":"Dorhout Mees SM","year":"2003","unstructured":"Dorhout Mees SM, Rinkel GJE, Hop JW, Algra A, van Gijn J. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review. Stroke. 2003;34(9):2285\u20132289."},{"issue":"4","key":"b29","series-title":"J Neurosurg","first-page":"633","article-title":"Population-based analysis of arteriovenous malformation treatment","volume":"95","author":"Hillman J","year":"2001","unstructured":"Hillman J. Population-based analysis of arteriovenous malformation treatment. J Neurosurg. 2001;95(4):633\u2013637."},{"issue":"5","key":"b30","series-title":"Stroke","first-page":"e29","article-title":"The New York Islands AVM Study: design, study progress, and initial results","volume":"34","author":"Stapf C","year":"2003","unstructured":"Stapf C, Mast H, Sciacca RR,  The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003;34(5):e29\u2013e33."},{"issue":"1","key":"b31","series-title":"Stroke","first-page":"21","article-title":"Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population","volume":"41","author":"Gabriel RA","year":"2010","unstructured":"Gabriel RA, Kim H, Sidney S,  Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke. 2010;41(1):21\u201326."},{"issue":"5","key":"b32","series-title":"Stroke","first-page":"1163","article-title":"Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS)","volume":"34","author":"Al-Shahi R","year":"2003","unstructured":"Al-Shahi R, Bhattacharya JJ, Currie DG,  Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34(5):1163\u20131169."},{"issue":"3","key":"b33","series-title":"Neurosurg Focus","first-page":"E7","article-title":"Natural history of brain arteriovenous malformations: a systematic review","volume":"37","author":"Abecassis IJ","year":"2014","unstructured":"Abecassis IJ, Xu DS, Batjer HH, Bendok BR. Natural history of brain arteriovenous malformations: a systematic review. Neurosurg Focus. 2014;37(3):E7."},{"issue":"9","key":"b34","series-title":"Neurology","first-page":"1350","article-title":"Predictors of hemorrhage in patients with untreated brain arteriovenous malformation","volume":"66","author":"Stapf C","year":"2006","unstructured":"Stapf C, Mast H, Sciacca RR,  Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350\u20131355."},{"issue":"5","key":"b35","series-title":"Stroke","first-page":"1243","article-title":"Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation","volume":"37","author":"Choi JH","year":"2006","unstructured":"Choi JH, Mast H, Sciacca RR,  Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke. 2006;37(5):1243\u20131247."},{"issue":"2","key":"b36","series-title":"Neurosurgery","first-page":"244","article-title":"Long-term excess mortality in 623 patients with brain arteriovenous malformations","volume":"63","author":"Laakso A","year":"2008","unstructured":"Laakso A, Dashti R, Sepp\u00e4nen J,  Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery. 2008;63(2):244\u2013255."},{"issue":"9917","key":"b37","series-title":"Lancet","first-page":"614","article-title":"Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial","volume":"383","author":"Mohr JP","year":"2014","unstructured":"Mohr JP, Parides MK, Stapf C,  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614\u2013621."},{"issue":"9","key":"b38","series-title":"Stroke","first-page":"2422","article-title":"Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use","volume":"44","author":"Garbe E","year":"2013","unstructured":"Garbe E, Kreisel SH, Behr S. Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use. Stroke. 2013;44(9):2422\u20132426."},{"issue":"Pt 2","key":"b39","series-title":"Brain","first-page":"665","article-title":"Single nucleotide polymorphisms associated with sporadic brain arteriovenous malformations: where do we stand?","volume":"136","author":"Sturiale CL","year":"2013","unstructured":"Sturiale CL, Puca A, Sebastiani P,  Single nucleotide polymorphisms associated with sporadic brain arteriovenous malformations: where do we stand? Brain. 2013;136(Pt 2):665\u2013681."},{"issue":"5","key":"b40","series-title":"Neurosurgery","first-page":"1137","article-title":"Inflammation and intracranial aneurysms","volume":"45","author":"Chyatte D","year":"1999","unstructured":"Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 1999;45(5):1137\u20131147."},{"issue":"5-6","key":"b41","series-title":"Cerebrovasc Dis","first-page":"332","article-title":"Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage","volume":"39","author":"Starke RM","year":"2015","unstructured":"Starke RM, Chalouhi N, Ding D, Hasan DM. Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis. 2015;39(5-6):332\u2013342."},{"issue":"22","key":"b42","series-title":"Neurology","first-page":"2280","article-title":"Low-dose aspirin and risk of intracranial bleeds: an observational study in UK general practice","volume":"89","author":"Cea Soriano L","year":"2017","unstructured":"Cea Soriano L, Gaist D, Soriano-Gabarr\u00f3 M, Bromley S, Garc\u00eda Rodr\u00edguez LA. Low-dose aspirin and risk of intracranial bleeds: an observational study in UK general practice. Neurology. 2017;89(22):2280\u20132287."},{"issue":"6","key":"b43","series-title":"Neurology","first-page":"566","article-title":"Antithrombotic drugs and risk of hemorrhagic stroke in the general population","volume":"81","author":"Garc\u00eda-Rodr\u00edguez LA","year":"2013","unstructured":"Garc\u00eda-Rodr\u00edguez LA, Gaist D, Morton J, Cookson C, Gonz\u00e1lez-P\u00e9rez A. Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology. 2013;81(6):566\u2013574."},{"issue":"5","key":"b44","series-title":"Neurosurgery","first-page":"845","article-title":"Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement","volume":"57","author":"Hoh BL","year":"2005","unstructured":"Hoh BL, Nogueira RG, Ledezma CJ, Pryor JC, Ogilvy CS. Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement. Neurosurgery. 2005;57(5):845\u2013849."},{"issue":"1","key":"b1","series-title":"Neurosurg Rev","first-page":"485","article-title":"Clinical practice for antiplatelet and anticoagulant therapy in neurosurgery: data from an Italian survey and summary of current recommendations\u2014part I, antiplatelet therapy","volume":"44","author":"Fiaschi P","year":"2021","unstructured":"Fiaschi P, Iaccarino C, Stefini R, Prior E, Prior A, Zona G. Clinical practice for antiplatelet and anticoagulant therapy in neurosurgery: data from an Italian survey and summary of current recommendations\u2014part I, antiplatelet therapy. Neurosurg Rev. 2021;44(1):485\u2013493."},{"issue":"1","key":"b2","series-title":"BMC Neurol","first-page":"98","article-title":"How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH)","volume":"21","author":"Prior A","year":"2021","unstructured":"Prior A, Fiaschi P, Iaccarino C,  How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH). BMC Neurol. 2021;21(1):98."},{"issue":"2","key":"b3","series-title":"J Neurosurg Sci","first-page":"236","article-title":"Anticoagulant therapy in high grade gliomas: a systematic review on state of the art and future perspectives","volume":"67","author":"Bianconi A","year":"2023","unstructured":"Bianconi A, Prior A, Zona G, Fiaschi P. Anticoagulant therapy in high grade gliomas: a systematic review on state of the art and future perspectives. J Neurosurg Sci. 2023;67(2):236\u2013240."},{"issue":"24","key":"b4","series-title":"J Am Coll Cardiol","first-page":"2987","article-title":"Meta-analysis of reversal agents for severe bleeding associated with direct oral anticoagulants","volume":"77","author":"G\u00f3mez-Outes A","year":"2021","unstructured":"G\u00f3mez-Outes A, Alcubilla P, Calvo-Rojas G,  Meta-analysis of reversal agents for severe bleeding associated with direct oral anticoagulants. J Am Coll Cardiol. 2021;77(24):2987\u20133001."},{"issue":"2","key":"b5","series-title":"J Neurol","first-page":"664","article-title":"Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials","volume":"269","author":"Wu T","year":"2022","unstructured":"Wu T, Lv C, Wu L,  Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. J Neurol. 2022;269(2):664\u2013675."},{"issue":"9","key":"b6","series-title":"BMJ Open","first-page":"e046741","article-title":"Continuation versus discontinuation of aspirin-based antiplatelet therapy for perioperative bleeding and ischaemic events in adults undergoing neurosurgery: protocol for a systematic review and meta-analysis","volume":"11","author":"Wang X","year":"2021","unstructured":"Wang X, Wang X, Yu Y, Han R. Continuation versus discontinuation of aspirin-based antiplatelet therapy for perioperative bleeding and ischaemic events in adults undergoing neurosurgery: protocol for a systematic review and meta-analysis. BMJ Open. 2021;11(9):e046741."},{"issue":"1","key":"b7","series-title":"Acta Neurochir (Wien)","first-page":"39","article-title":"Risks and benefits of continuation and discontinuation of aspirin in elective craniotomies: a systematic review and pooled-analysis","volume":"165","author":"Rychen J","year":"2023","unstructured":"Rychen J, Saemann A, Fingerlin T,  Risks and benefits of continuation and discontinuation of aspirin in elective craniotomies: a systematic review and pooled-analysis. Acta Neurochir (Wien). 2023;165(1):39\u201347."},{"issue":"1","key":"b8","series-title":"Neurocrit Care","first-page":"6","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine","volume":"24","author":"Frontera JA","year":"2016","unstructured":"Frontera JA, Lewin JJ III, Rabinstein AA,  Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24(1):6\u201346."},{"issue":"7829","key":"b9","series-title":"BMJ","first-page":"d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JPT","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC,  The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(7829):d5928."},{"issue":"8","key":"b10","series-title":"Intern Emerg Med","first-page":"1227","article-title":"Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study","volume":"13","author":"Sturiale CL","year":"2018","unstructured":"Sturiale CL, Pignotti F, Giordano M,  Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study. Intern Emerg Med. 2018;13(8):1227\u20131232."},{"issue":"12","key":"b11","series-title":"Ann Hematol","first-page":"1959","article-title":"Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation","volume":"91","author":"Edwards CP","year":"2012","unstructured":"Edwards CP, Shehata N, Faughnan ME. Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation. Ann Hematol. 2012;91(12):1959\u20131968."},{"issue":"10","key":"b12","series-title":"Lancet Neurol","first-page":"935","article-title":"Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis","volume":"18","author":"Zuurbier SM","year":"2019","unstructured":"Zuurbier SM, Hickman CR, Tolias CS,  Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol. 2019;18(10):935\u2013941."},{"issue":"6","key":"b13","series-title":"J Neurosurg","first-page":"1922","article-title":"Antithrombotic medication and bleeding risk in patients with cerebral cavernous malformations: a cohort study","volume":"130","author":"Bervini D","year":"2019","unstructured":"Bervini D, Jaeggi C, Mordasini P, Schucht P, Raabe A. Antithrombotic medication and bleeding risk in patients with cerebral cavernous malformations: a cohort study. J Neurosurg. 2019;130(6):1922\u20131930."},{"issue":"12","key":"b14","series-title":"Stroke","first-page":"3196","article-title":"Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations","volume":"43","author":"Schneble HM","year":"2012","unstructured":"Schneble HM, Soumare A, Herv\u00e9 D,  Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke. 2012;43(12):3196\u20133199."},{"issue":"1","key":"b15","series-title":"J Neurosurg","first-page":"43","article-title":"Use of antithrombotic agents in patients with intracerebral cavernous malformations","volume":"118","author":"Flemming KD","year":"2013","unstructured":"Flemming KD, Link MJ, Christianson TJH, Brown RD Jr. Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg. 2013;118(1):43\u201346."},{"key":"b16","series-title":"Clin Neurol Neurosurg","first-page":"93","article-title":"Impact of antithrombotic treatment on clinical outcomes after craniotomy for unruptured intracranial aneurysm","volume":"161","author":"Nakamizo A","year":"2017","unstructured":"Nakamizo A, Michiwaki Y, Kawano Y,  Impact of antithrombotic treatment on clinical outcomes after craniotomy for unruptured intracranial aneurysm. Clin Neurol Neurosurg. 2017;161:93\u201397."},{"issue":"6","key":"b17","series-title":"World Neurosurg","first-page":"1127","article-title":"Aspirin and aneurysmal subarachnoid hemorrhage","volume":"82","author":"Gross BA","year":"2014","unstructured":"Gross BA, Rosalind Lai PM, Frerichs KU, Du R. Aspirin and aneurysmal subarachnoid hemorrhage. World Neurosurg. 2014;82(6):1127\u20131130."},{"issue":"6","key":"b18","series-title":"J Neurosurg","first-page":"1611","article-title":"Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment","volume":"119","author":"Simard JM","year":"2013","unstructured":"Simard JM, Aldrich EF, Schreibman D, James RF, Polifka A, Beaty N. Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment. J Neurosurg. 2013;119(6):1611\u20131619."},{"issue":"5","key":"b19","series-title":"Interv Neuroradiol","first-page":"532","article-title":"Outcome of flow diverter placement for intracranial aneurysm with dual antiplatelet therapy and oral anticoagulant therapy","volume":"26","author":"Fujii T","year":"2020","unstructured":"Fujii T, Oishi H, Teranishi K, Yatomi K, Suzuki K, Arai H. Outcome of flow diverter placement for intracranial aneurysm with dual antiplatelet therapy and oral anticoagulant therapy. Interv Neuroradiol. 2020;26(5):532\u2013538."},{"issue":"6","key":"b20","series-title":"J Neurosurg","first-page":"921","article-title":"Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage","volume":"101","author":"Toussaint LG III","year":"2004","unstructured":"Toussaint LG III, Friedman JA, Wijdicks EFM,  Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;101(6):921\u2013925."},{"issue":"1","key":"b21","series-title":"Neurosurgery","first-page":"77","article-title":"Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with unruptured aneurysms","volume":"84","author":"Narata AP","year":"2019","unstructured":"Narata AP, Amelot A, Bibi R,  Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with unruptured aneurysms. Neurosurgery. 2019;84(1):77\u201383."},{"key":"b22","series-title":"World Neurosurg","first-page":"e132","article-title":"Patients taking antithrombotic medications present less frequently with ruptured aneurysms","volume":"136","author":"Nisson PL","year":"2020","unstructured":"Nisson PL, Meybodi T, Secomb TW, Berger GK, Roe DJ, Lawton MT. Patients taking antithrombotic medications present less frequently with ruptured aneurysms. World Neurosurg. 2020;136:e132\u2013e140."},{"issue":"11","key":"b23","series-title":"Stroke","first-page":"3156","article-title":"Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture","volume":"42","author":"Hasan DM","year":"2011","unstructured":"Hasan DM, Mahaney KB, Brown RD Jr,  Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke. 2011;42(11):3156\u20133162."},{"issue":"2","key":"b24","series-title":"J Neurosurg","first-page":"537","article-title":"The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis","volume":"126","author":"Dasenbrock HH","year":"2017","unstructured":"Dasenbrock HH, Yan SC, Gross BA,  The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis. J Neurosurg. 2017;126(2):537\u2013547."},{"issue":"2","key":"b25","series-title":"J Neurosurg","first-page":"302","article-title":"Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis","volume":"127","author":"Brinjikji W","year":"2017","unstructured":"Brinjikji W, Iyer VN, Wood CP, Lanzino G. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis. J Neurosurg. 2017;127(2):302\u2013310."},{"issue":"2","key":"b26","series-title":"Lancet Neurol","first-page":"166","article-title":"Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data","volume":"15","author":"Horne MA","year":"2016","unstructured":"Horne MA, Flemming KD, Su IC,  Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol. 2016;15(2):166\u2013173."},{"issue":"5","key":"b27","series-title":"Stroke","first-page":"1210","article-title":"Aspirin and risk of subarachnoid hemorrhage: systematic review and meta-analysis","volume":"48","author":"Phan K","year":"2017","unstructured":"Phan K, Moore JM, Griessenauer CJ, Ogilvy CS, Thomas AJ. Aspirin and risk of subarachnoid hemorrhage: systematic review and meta-analysis. Stroke. 2017;48(5):1210\u20131217."},{"issue":"9","key":"b28","series-title":"Stroke","first-page":"2285","article-title":"Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review","volume":"34","author":"Dorhout Mees SM","year":"2003","unstructured":"Dorhout Mees SM, Rinkel GJE, Hop JW, Algra A, van Gijn J. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review. Stroke. 2003;34(9):2285\u20132289."},{"issue":"4","key":"b29","series-title":"J Neurosurg","first-page":"633","article-title":"Population-based analysis of arteriovenous malformation treatment","volume":"95","author":"Hillman J","year":"2001","unstructured":"Hillman J. Population-based analysis of arteriovenous malformation treatment. J Neurosurg. 2001;95(4):633\u2013637."},{"issue":"5","key":"b30","series-title":"Stroke","first-page":"e29","article-title":"The New York Islands AVM Study: design, study progress, and initial results","volume":"34","author":"Stapf C","year":"2003","unstructured":"Stapf C, Mast H, Sciacca RR,  The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003;34(5):e29\u2013e33."},{"issue":"1","key":"b31","series-title":"Stroke","first-page":"21","article-title":"Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population","volume":"41","author":"Gabriel RA","year":"2010","unstructured":"Gabriel RA, Kim H, Sidney S,  Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke. 2010;41(1):21\u201326."},{"issue":"5","key":"b32","series-title":"Stroke","first-page":"1163","article-title":"Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS)","volume":"34","author":"Al-Shahi R","year":"2003","unstructured":"Al-Shahi R, Bhattacharya JJ, Currie DG,  Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34(5):1163\u20131169."},{"issue":"3","key":"b33","series-title":"Neurosurg Focus","first-page":"E7","article-title":"Natural history of brain arteriovenous malformations: a systematic review","volume":"37","author":"Abecassis IJ","year":"2014","unstructured":"Abecassis IJ, Xu DS, Batjer HH, Bendok BR. Natural history of brain arteriovenous malformations: a systematic review. Neurosurg Focus. 2014;37(3):E7."},{"issue":"9","key":"b34","series-title":"Neurology","first-page":"1350","article-title":"Predictors of hemorrhage in patients with untreated brain arteriovenous malformation","volume":"66","author":"Stapf C","year":"2006","unstructured":"Stapf C, Mast H, Sciacca RR,  Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350\u20131355."},{"issue":"5","key":"b35","series-title":"Stroke","first-page":"1243","article-title":"Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation","volume":"37","author":"Choi JH","year":"2006","unstructured":"Choi JH, Mast H, Sciacca RR,  Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke. 2006;37(5):1243\u20131247."},{"issue":"2","key":"b36","series-title":"Neurosurgery","first-page":"244","article-title":"Long-term excess mortality in 623 patients with brain arteriovenous malformations","volume":"63","author":"Laakso A","year":"2008","unstructured":"Laakso A, Dashti R, Sepp\u00e4nen J,  Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery. 2008;63(2):244\u2013255."},{"issue":"9917","key":"b37","series-title":"Lancet","first-page":"614","article-title":"Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial","volume":"383","author":"Mohr JP","year":"2014","unstructured":"Mohr JP, Parides MK, Stapf C,  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614\u2013621."},{"issue":"9","key":"b38","series-title":"Stroke","first-page":"2422","article-title":"Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use","volume":"44","author":"Garbe E","year":"2013","unstructured":"Garbe E, Kreisel SH, Behr S. Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use. Stroke. 2013;44(9):2422\u20132426."},{"issue":"Pt 2","key":"b39","series-title":"Brain","first-page":"665","article-title":"Single nucleotide polymorphisms associated with sporadic brain arteriovenous malformations: where do we stand?","volume":"136","author":"Sturiale CL","year":"2013","unstructured":"Sturiale CL, Puca A, Sebastiani P,  Single nucleotide polymorphisms associated with sporadic brain arteriovenous malformations: where do we stand? Brain. 2013;136(Pt 2):665\u2013681."},{"issue":"5","key":"b40","series-title":"Neurosurgery","first-page":"1137","article-title":"Inflammation and intracranial aneurysms","volume":"45","author":"Chyatte D","year":"1999","unstructured":"Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 1999;45(5):1137\u20131147."},{"issue":"5-6","key":"b41","series-title":"Cerebrovasc Dis","first-page":"332","article-title":"Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage","volume":"39","author":"Starke RM","year":"2015","unstructured":"Starke RM, Chalouhi N, Ding D, Hasan DM. Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis. 2015;39(5-6):332\u2013342."},{"issue":"22","key":"b42","series-title":"Neurology","first-page":"2280","article-title":"Low-dose aspirin and risk of intracranial bleeds: an observational study in UK general practice","volume":"89","author":"Cea Soriano L","year":"2017","unstructured":"Cea Soriano L, Gaist D, Soriano-Gabarr\u00f3 M, Bromley S, Garc\u00eda Rodr\u00edguez LA. Low-dose aspirin and risk of intracranial bleeds: an observational study in UK general practice. Neurology. 2017;89(22):2280\u20132287."},{"issue":"6","key":"b43","series-title":"Neurology","first-page":"566","article-title":"Antithrombotic drugs and risk of hemorrhagic stroke in the general population","volume":"81","author":"Garc\u00eda-Rodr\u00edguez LA","year":"2013","unstructured":"Garc\u00eda-Rodr\u00edguez LA, Gaist D, Morton J, Cookson C, Gonz\u00e1lez-P\u00e9rez A. Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology. 2013;81(6):566\u2013574."},{"issue":"5","key":"b44","series-title":"Neurosurgery","first-page":"845","article-title":"Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement","volume":"57","author":"Hoh BL","year":"2005","unstructured":"Hoh BL, Nogueira RG, Ledezma CJ, Pryor JC, Ogilvy CS. Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement. Neurosurgery. 2005;57(5):845\u2013849."}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/55\/4\/article-pE14.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/55\/4\/article-pE14.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/55\/4\/article-pE14.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:24:03Z","timestamp":1779524643000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/55\/4\/article-pE14.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":88,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2023.7.focus23117","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}